Q2
BNGO — Q2 2026 Financial Report Analysis
Bionano's Q2 2026 revenue rose 21% to $8.2M on stronger instrument and flowcell sales, but after repaying its convertible debt it has only $9.9M in cash and investments against $10.4M of first-half cash burn, and the 10-Q carries a going-concern warning.